Abdala vaccine candidate: 92.28% efficacy in its three doses
The news was announced this Monday in Havana by the Center for Genetic Engineering and Biotechnology (CIGB).
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
